Dolasetron
- TRADE NAME: Anzemet (Sanofi-Aventis)
- INDICATIONS: Prevention of nausea and vomiting
- CLASS: 5-HT3 antagonist, Serotonin type 3 receptor antagonist (CCR5 co-receptor antagonist)
- HALF-LIFE: 8 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alfuzosin, Apomorphine, Artemether/Lumefantrine, Chloroquine, Ciprofloxacin, Conivaptan, Dronedarone, Gadobutrol, Indacaterol, Nilotinib, Pimozide, QT prolonging agents, Quetiapine, Quinine, Tetrabenazine, Thioridazine, Tocilizumab, Toremifene, Vandetanib, Vemurafenib, Ziprasidone
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
NEUROMUSCULAR/SKELETAL.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric